160 related articles for article (PubMed ID: 22798664)
1. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
[TBL] [Abstract][Full Text] [Related]
2. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.
Verhagen AM; Wallace ME; Goradia A; Jones SA; Croom HA; Metcalf D; Collinge JE; Maxwell MJ; Hibbs ML; Alexander WS; Hilton DJ; Kile BT; Starr R
J Immunol; 2009 Feb; 182(4):2020-9. PubMed ID: 19201855
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.
Moon BG; Takaki S; Nishizumi H; Yamamoto T; Takatsu K
Cell Immunol; 2004 Apr; 228(2):110-8. PubMed ID: 15219462
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity.
Hibbs ML; Harder KW; Armes J; Kountouri N; Quilici C; Casagranda F; Dunn AR; Tarlinton DM
J Exp Med; 2002 Dec; 196(12):1593-604. PubMed ID: 12486102
[TBL] [Abstract][Full Text] [Related]
6. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
[TBL] [Abstract][Full Text] [Related]
7. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice.
Tsantikos E; Quilici C; Harder KW; Wang B; Zhu HJ; Anderson GP; Tarlinton DM; Hibbs ML
J Immunol; 2009 Aug; 183(4):2484-94. PubMed ID: 19620313
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
[TBL] [Abstract][Full Text] [Related]
9. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
10. Genetic evidence for Lyn as a negative regulator of IL-4 signaling.
Janas ML; Hodgkin P; Hibbs M; Tarlinton D
J Immunol; 1999 Oct; 163(8):4192-8. PubMed ID: 10510355
[TBL] [Abstract][Full Text] [Related]
11. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice.
Oracki SA; Tsantikos E; Quilici C; Light A; Schmidt T; Lew AM; Martin JE; Smith KG; Hibbs ML; Tarlinton DM
J Immunol; 2010 Jan; 184(2):757-63. PubMed ID: 19966213
[TBL] [Abstract][Full Text] [Related]
12. MyD88-dependent autoimmune disease in Lyn-deficient mice.
Silver KL; Crockford TL; Bouriez-Jones T; Milling S; Lambe T; Cornall RJ
Eur J Immunol; 2007 Oct; 37(10):2734-43. PubMed ID: 17853409
[TBL] [Abstract][Full Text] [Related]
13. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.
Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T
Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145
[TBL] [Abstract][Full Text] [Related]
14. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
Takeshita H; Taniuchi I; Kato J; Watanabe T
Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
[TBL] [Abstract][Full Text] [Related]
17. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.
Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB
Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140
[TBL] [Abstract][Full Text] [Related]
18. Signaling mutations and autoimmunity.
Yu CC; Mamchak AA; DeFranco AL
Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
[TBL] [Abstract][Full Text] [Related]
19. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
20. Positive and negative roles of the tyrosine kinase Lyn in B cell function.
DeFranco AL; Chan VW; Lowell CA
Semin Immunol; 1998 Aug; 10(4):299-307. PubMed ID: 9695186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
